Glaucoma implant with valveless flow bias

• US 20040024345A1
• Filed: 04/18/2003
• Published: 02/05/2004
• Est. Priority Date: 04/19/2002
• Status: Abandoned Application

• Current Assignee: Glaukos Corporation
• Original Assignee: Glaukos Corporation
• Inventors: Gharib, Morteza, Tu, Hosheng
• Application Number:
  US10/420,354
• Publication Number:
  US 20040024345A1
• Time in Patent Office: Days
• US Class Current: 604/8
• CPC Class Codes: A61F 9/00781 Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment drainage implants in general A61M27/002

Abstract

An implant for treating glaucoma in an eye is described, the implant including an inflow portion sized and shaped to fit in the anterior chamber of the eye; an outflow portion sized and shaped fit in at least one of Schlemm'"'"'s canal, an aqueous collector channel, and an episcleral vein; and a lumen that permits fluid communication from the inflow portion to the outflow portion of the implant, the lumen being configured such that, for a first flow F(i-o) through the lumen in a direction from an inflow end of the implant to an outflow end of the implant, at a first pressure difference P(i-o) between a higher pressure at the inflow end and a lower pressure at the outflow end, said first flow F(i-o) is greater than a second flow F(o-i) through the lumen in a direction from the outflow end to the inflow end, at a second pressure difference P(o-i) between a higher pressure at the outflow end and a lower pressure at the inflow end, where the magnitude of P(o-i) is equal to P(i-o).

Claims

1. An implant for treating glaucoma in an eye, the implant comprising:

an inflow portion sized and shaped to fit in the anterior chamber of the eye;

an outflow portion sized and shaped to fit in at least one of Schlemm'"'"'s canal, an aqueous collector channel, and an episcleral vein; and

a lumen that permits fluid communication from the inflow portion to the outflow portion of the implant, the lumen being configured such that (i) a pressure difference AP between a higher pressure at the inflow end and a lower pressure at the outflow end will yield a flow F(i-o) through the lumen in a direction from an inflow end of the implant to an outflow end of the implant, and (ii) a pressure difference of the same magnitude Δ

P between a higher pressure at the outflow end and a lower pressure at the inflow end will yield a flow F(o-i) through the lumen in a direction from the outflow end to the inflow end, said flow F(i-o) being significantly greater than said flow F(o-i).

2. The implant of claim 1, further comprising a material type selected from the group consisting of porous material, semi-rigid material, soft material, hydrophilic material, hydrophobic material, hydrogel, elastic material, meshed material, and expandable material.

3. The implant of claim 1, further comprising a material selected from the group consisting of silicone and polyurethane.

4. The implant of claim 1, further comprising a material selected from the group consisting of polyvinyl alcohol, polyvinyl pyrolidone, collagen, heparinized collagen, tetrafluoroethylene, fluorinated polymer, fluorinated elastomer, flexible fused silica, polyolefin, polyester, polysilicon, stainless steel, titanium, and Nitinol.

5. The implant of claim 1, further comprising a material selected from the group consisting of Teflon, polyimide, hydrogel, heparin, and a drug.

6. The implant of claim 5, wherein the drug is selected from the group consisting of intraocular pressure-lowering agents, anti-inflammatory agents, anti-angiogenic agents, optic nerve protecting agents, and antiproliferative agents.

7. The implant of claim 1, wherein an outside diameter of the implant is between about 20 μ

m and about 500 μ

m.

8. The implant of claim 1, wherein a luminal diameter of the implant is between about 10 μ

m and about 150 μ

m.

9. The implant of claim 1, wherein a length of the lumen is between about 100 μ

m and about 300 μ

m.

10. An implant for treating glaucoma in an eye, the implant comprising:

an inflow portion sized and shaped to fit in the anterior chamber of the eye;

an outflow portion sized and shaped fit in at least one of Schlemm'"'"'s canal, an aqueous collector channel, and an episcleral vein; and

a lumen that permits fluid communication from the inflow portion to the outflow portion of the implant, the lumen gradually decreasing in cross-sectional area in a direction extending from the outflow portion to the inflow portion.

11. An implant for treating glaucoma in an eye, the implant comprising:

an inflow portion sized and shaped to fit in the anterior chamber of the eye;

an outflow portion sized and shaped fit in at least one of Schlemm'"'"'s canal, an aqueous collector channel, and an episcleral vein; and

a lumen that permits fluid communication from the inflow portion to the outflow portion of the implant, the lumen having a taper such that a first cross-sectional area of the lumen in the outflow portion is greater than a second cross-sectional area of the lumen in the inflow portion.

12. A method of treating glaucoma in an eye, comprising:

providing an implant having a lumen that permits fluid communication from an inflow end to an outflow end of the implant, the lumen being configured such that (i) a pressure difference AP between a higher pressure at the inflow end and a lower pressure at the outflow end will yield a flow F(i-o) through the lumen in a direction from an inflow end of the implant to an outflow end of the implant, and (ii) a pressure difference of the same magnitude Δ

P between a higher pressure at the outflow end and a lower pressure at the inflow end will yield a flow F(o-i) through the lumen in a direction from the outflow end to the inflow end, said flow F(i-o) being significantly greater than said flow F(o-i); and

placing the implant into the eye, such that the inflow end of the implant is in the anterior chamber of the eye, and the outflow end of the implant is in at least one of Schlemm'"'"'s canal, an aqueous collector channel, and an episcleral vein.

13. The method of claim 12, wherein the placing comprises inserting the implant into the anterior chamber through a corneal incision.

14. The method of claim 12, wherein the placing comprises inserting the implant into the eye through a scleral incision.